Research Article | | Peer-Reviewed

Socioprofessional Impact on Patients with Chronic Kidney Disease at Aristide Le Dantec Hospital in Dakar: Out-of-Pocket Expenditures Burden and Catastrophic Household Finances

Received: 25 May 2026     Accepted: 8 June 2026     Published: 24 July 2026
Views:       Downloads:
Abstract

Background: Chronic kidney disease (CKD) represents a major public health burden in sub-Saharan Africa, predominantly affecting young working-age adults. Despite free dialysis policies implemented in Senegal since 2012, the broader socioeconomic consequences of end-stage kidney disease (ESKD) on patients and their families remained poorly documented. Aim: This study aimed to estimate the socioprofessional and economic impact of dialysis on ESKD patients and their families in 2019. Setting: The nephrology and dialysis department of Aristide Le Dantec Hospital, a national level III referral center in Dakar, Senegal. Methods: An analytical cross-sectional study was conducted from January to December 2019. Data were collected through medical record reviews and face-to-face interviews. Direct and indirect costs were calculated, and catastrophic health expenditure was assessed using a 20% annual household income threshold. Results: A total of 89 patients were enrolled. The mean age was 47.83 years and 87.36% had no health insurance. Weekly working hours declined from 38.32 before diagnosis to 4.93 hours after. Job loss affected 59.09% of patients. Nearly all patients (89.53%) reported social repercussions, primarily activity limitations. Additionally, 43.68% sold personal assets to cover treatment costs, and 18.39% contracted loans. Catastrophic health expenditure affected 95.98% of patients, with out-of-pocket costs representing 52.86% of total management expenditures. Conclusion: Despite state subsidies, ESKD imposed a devastating socioeconomic burden on patients and families. Strengthening health insurance coverage and expanding social protection for CKD patients is strongly recommended. Contribution: This study provides critical evidence on the socioprofessional consequences of ESKD in West Africa, informing equitable health policy and resource allocation for kidney disease management in low- and middle-income countries.

Published in World Journal of Public Health (Volume 11, Issue 3)
DOI 10.11648/j.wjph.20261103.14
Page(s) 264-270
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2026. Published by Science Publishing Group

Keywords

Chronic Kidney Disease, Socioprofessional Impact, Out-of-Pocket Expenditures, Catastrophic Health Expenditure, Dialysis, Senegal, Sub-Saharan Africa

1. Introduction
Chronic kidney disease is defined as a decrease in creatinine clearance below 90 ml/min/1.73 m2 . Various communicable and non-communicable diseases lead to renal complications, and many individuals with kidney disease lack access to care.
Chronic kidney disease is a global public health issue. In 2015, more than 353 million people (5% of the world's population) suffered from CKD . In developed countries it primarily affects elderly individuals, whereas in Africa it predominantly occurs in young working-age adults, increasing at an annual rate of 5% in industrialized nations.
In the United States the prevalence is approximately 13%, affecting nearly 20 million Americans, with 650,000 patients on dialysis in 2010 . In sub-Saharan Africa the prevalence is 13.9%, ranging from 2% in Côte d'Ivoire to 30.2% in Zimbabwe .
In Senegal the prevalence is estimated at 4.9%. In 2019 the number of patients on dialysis in public facilities rose to 842, including 50 on peritoneal dialysis . Since 2012 the Government has made dialysis free of charge, increased center numbers from 4 to 23 , and enacted Law n° 2015-22 on organ donation and Decree n° 2018-1583 establishing the NCDT . Despite these efforts, residual costs continue to burden patients and families.
The objective of this study was to estimate the socioprofessional and economic impact of dialysis on ESKD patients and their families in 2019.
2. Materials and Methods
2.1. Study Setting
The study was conducted in the nephrology, dialysis, and kidney transplantation department of Aristide Le Dantec Hospital (HALD) in Dakar, a national level III referral center.
2.2. Type and Period of Study
Analytical cross-sectional study with an economic focus, conducted from January 2 to December 31, 2019.
2.3. Study Population
2.3.1. Inclusion Criteria
ESKD patients regularly dialyzed at HALD for at least one year during 2019 with a complete medical record.
2.3.2. Exclusion Criteria
Patients who refused to participate, whose health condition prevented answering questions, or whose records were incomplete or lost.
2.3.3. Recruitment
Exhaustive recruitment of all patients meeting inclusion criteria.
2.4. Data Collection
Medical record review combined with face-to-face interviews. A structured form collected sociodemographic, clinical, socioprofessional, and cost data.
2.5. Variables and Cost Calculations
Indirect costs assessed as productivity loss (annual income before minus current income). Income thresholds per 2017 HEA Senegal: low <769,450 FCFA; middle 769,450–1,388,100 FCFA; high >2,234,500 FCFA (1 euro=655.96 FCFA; 1 USD=571.30 FCFA). Catastrophic health expenditure (CHE) defined as annual health expenditure ≥20% of annual household income . Direct costs included transportation, medications, laboratory, radiology, consultations, and accommodation.
2.6. Data Analysis
Data entered in Excel and analyzed using Epi Info 7. Descriptive statistics and t-test for cost comparisons between dialysis modalities (significance: 0.05).
2.7. Ethical Considerations
Informed consent obtained from all participants. Strict confidentiality and anonymity assured. Legal guardian used for patients under 18.
3. Results
3.1. Descriptive Results
A total of 89 patients were enrolled. Mean age 47.83 ± 13.40 years (range 15–83). Females 51.96% (n=53). Among 87 patients, 71.26% were married. Informal workers 44.44%; no employment 37.37%. No health insurance: 87.36% (Table 1).
Table 1. Distribution of Patient Characteristics.

Sociodemographic characteristics

N (N=89)

Percentage (%)

Mean

Age (years): <20 / 20–29 / 30–39 / 40–49 / 50–59 / >60

2 / 7 / 15 / 25 / 21 / 19

2 / 8 / 17 / 28 / 24 / 21

47.83 ± 13.40 years

Gender: Male / Female

43 / 57

48.04 / 51.96

Sex ratio = 0.92

Marital status: Married / Single / Divorced / Widowed

63 / 19 / 3 / 4

71.26 / 20.69 / 3.45 / 4.60

Professional activity: Informal / No activity / Formal / Student

44 / 37 / 12 / 6

44.44 / 37.37 / 12.12 / 6.06

Health insurance: Private / Mutual org / None

11 / 0 / 78

12.64 / 0 / 87.36

3.2. Socioprofessional Impact
3.2.1. Primary Household Earner
Among 86 patients, 29 (33.72%) were the primary earner before ESKD diagnosis.
3.2.2. Working Hours
Mean weekly hours declined from 38.32 ± 27.75 before diagnosis to 4.93 ± 10.99 after.
3.2.3. Monthly Occasional Assistance
20 patients (23.81%) received monthly assistance: 85% from family, 15% from employers. Mean: 48,894 ± 64,277 FCFA.
3.2.4. Impact on Professional Life
76.74% (n=66) of 86 patients confirmed professional life impact. Job loss was the main consequence (59.09%, n=39) (Figure 1).
Figure 1. Distribution of patients according to the impact of CKD on professional life and dialysis modality.
3.2.5. Impact on Social Life
89.53% (n=77) reported social repercussions. Activity limitations accounted for 51.95% (n=40) of cases.
3.2.6. Borrowing and Asset Sales
18.39% (n=16) resorted to loans (mean: 229,615 ± 257,443 FCFA). 43.68% (n=38) sold personal or family assets to finance care (Table 2).
Table 2. Distribution of dialysis patients according to assets sold, by dialysis modality (Freq. = Frequency; n = number of patients).

Category

Peritoneal Dialysis (n=7)

Hemodialysis (n=31)

Total (n=38)

Freq.

%

Freq.

%

Freq.

%

Land plot

1

14.29

15

48.39

16

42.11

Gold / Jewelry

4

57.14

7

22.58

11

28.95

Work equipment

1

14.29

6

19.35

7

18.42

Household appliance

1

14.29

2

6.45

3

7.89

Transportation / Vehicle

1

3.23

1

2.63

Total

7

100.00

31

100.00

38

100.00

3.2.7. Stigmatization and Catastrophic Expenditure
8.14% (n=7) experienced stigmatization from neighbors. 95.98% of patients faced catastrophic health expenditure (Figure 2).
Figure 2. Distribution according to the share of ESKD management expenditures on patient income by dialysis modality.
3.3. Total Management Costs
Hemodialysis total costs: 1,136,580,121 FCFA (54.79% patient-borne) (Table 3). Peritoneal dialysis: 345,342,284 FCFA (46.52% patient-borne) (Table 4). All dialysis patients: 1,481,922,405 FCFA (52.86% patient-borne) (Table 5).
Table 3. Distribution of management costs for hemodialysis patients according to funding sources.

Cost types

Total amount (FCFA)

Patients and/or families Amount (%)

State Amount (%)

Direct medical costs

638,583,502

124,719,502 (19.53%)

513,864,000 (80.47%)

Direct non-medical costs

151,416,823

151,416,823 (100%)

0 (0%)

Indirect costs

346,579,796

346,579,796 (100%)

0 (0%)

Total costs

1,136,580,121

622,716,121 (54.79%)

513,864,000 (45.21%)

Table 4. Distribution of management costs for peritoneal dialysis patients according to funding sources.

Cost types

Total amount (FCFA)

Patients and/or families Amount (%)

State Amount (%)

Direct medical costs

217,413,140

32,713,940 (15.05%)

184,699,200 (84.95%)

Direct non-medical costs

19,044,144

19,044,144 (100%)

0 (0%)

Indirect costs

108,885,000

108,885,000 (100%)

0 (0%)

Total costs

345,342,284

160,643,084 (46.52%)

184,699,200 (53.48%)

Table 5. Distribution of management costs for all dialysis patients according to funding sources.

Cost types

Total amount (FCFA)

Patients and/or families Amount (%)

State Amount (%)

Direct medical costs

855,996,642

157,433,442 (18.39%)

698,563,200 (81.61%)

Direct non-medical costs

170,460,967

170,460,967 (100%)

0 (0%)

Indirect costs

455,464,796

455,464,796 (100%)

0 (0%)

Total costs

1,481,922,405

783,359,205 (52.86%)

698,563,200 (47.14%)

4. Discussion
4.1. Study Limitations
This study was conducted in 2019 prior to the COVID-19 pandemic in Senegal (the first case was recorded in March 2020); therefore, any reference to COVID-19 as a contextual factor is not applicable to this study period. Additional limitations include reliance on patient recall for some cost items, receipts not always available for verification, limited dialysis bed capacity with 13–19-month waiting times, and exclusion of patients from private-sector facilities.
4.2. Epidemiological Data
4.2.1. Age
Mean age 47.83 years, similar to Dakar , Saint-Louis , India , and Madagascar . While KANE Y et al. had found a mean age of 41.3 years, with extremes of 12 and 72 years . Higher means in UK (58.2) , US (54.3) , and France (76) reflect population aging.
4.2.2. Gender
Female predominance (51.96%, sex ratio 0.92) may reflect higher cardiovascular risk factors among Senegalese women . 72.55% were on hemodialysis; mean session duration 5.1 ± 2.79 hours; mean dialysis vintage 6.57 ± 3.93 years.
4.2.3. Education Level
More than half 60.68% were educated, primarily at the secondary level (30.34%) . This contrasts with other settings, such as Congo , Rabat, Morocco , northern Senegal in 2012 , and rural Haiti , where it was found that most of these patients had less than 6 years of schooling. In our case, this could be explained by the setting in which we conducted our research, which is located in the heart of the city, limiting access to a large portion of the population, and leading us to assume that the population that frequented this institution is not a true representation of our society as a whole.
4.3. Socioprofessional and Economic Impact
The progression from CKD stage 3 to CKD stages 4-5 was associated with a 1.3 à 4.2 fold increase in costs, with the highest costs associated with end-stage renal disease at $20,110 to $100,593 per patient .
One in three families lost their primary breadwinner. Weekly hours collapsed from 38.32 to 4.93. Assistance received by 23.81%, mostly from families (85%), similar to Ahoui et al. . Patient-borne costs (54.79% hemodialysis) exceed Indian estimates but are comparable to Ethiopia . Nearly all (95.98%) faced CHE, consistent with India (93.4%) and Ethiopia (90%) . A Thai study found lower EuroQol-5D scores in CHE patients (0.76 vs. 0.82, p<0.001) . Social disruption: 89.53%. Stigmatization: 8.14% vs. 4.47% in Benin .
5. Conclusions
CKD constitutes a major global public health issue. Despite state subsidies, ESKD imposed a devastating socioeconomic burden on patients and families in Senegal. Strengthening health insurance and expanding social protection for CKD patients is strongly recommended to achieve universal health coverage and the Sustainable Development Goals.
Abbreviations

CKD

Chronic Kidney Disease

ESKD

End-Stage Kidney Disease

FCFA

Franc De La Communauté Financière Africaine

HALD

Hôpital Aristide Le Dantec

CHE

Catastrophic Health Expenditure

CAPD

Continuous Ambulatory Peritoneal Dialysis

ANACMU

Agence Nationale De La Couverture Maladie Universelle

PNA

Pharmacie Nationale d'Approvisionnement

NCDT

National Council for Donation and Transplantation

UHC

Universal Health Coverage

Author Contributions
Mbathio Diop: Conceptualization, Methodology, Writing – original draft, Writing – review & editing
Mareme Maty Dioum: Data curation, Formal Analysis, Investigation
Morel Fabrice Bignon Aguiar: Data curation, Investigation, Writing – original draft
Mamadou Makhtar Mbacke Leye: Project administration, Supervision, Validation, Writing – review & editing
Data Availability Statement
The data supporting the outcome of this research work has been reported in this manuscript.
Conflicts of Interest
The authors declare no conflicts of interest.
References
[1] Cuen FR. Chronic renal failure and chronic kidney disease]. In: Néphrologie, 8e edition, chap. 15. Available from:
[2] Ramilitiana B, et al. A retrospective study on the incidence of chronic kidney disease. Thèse médecine. 2016; 23.
[3] Ferris ME, Gipson DS, Kimmel PL, Eggers PW. Trends in treatment and outcomes of survival of adolescents initiating end-stage renal disease care in the United States. Pediatrics. 2006; 117(4): 1212–1219.
[4] Stanifer JW, et al. The epidemiology of CKD in sub-Saharan Africa: a systematic review and meta-analysis. Lancet Global Health. 2014; 2(3): e174–81.
[5] Ndiaye AS. Contribution of the PNA Director on the free management of kidney disease in Senegal. Ministère de la Santé. 2026.
[6] Niang A, et al. Evaluation of cardiac complications among chronic hemodialysis in Dakar. Pan Afr Med J. 2016; 23: 43.
[7] Seck S, et al. Prevalence survey of CKD in northern Senegal. Néphrologie & Thérapeutique. 2014; 10(5): 399.
[8] Falodia J, Singla MK. CKD epidemiology and risk factors. Clinical Queries: Nephrology. 2012; 1(4): 249–52.
[9] Kane K, et al. Decentralization of dialysis in Senegal: one-year experience at the Tambacounda center. ESJ. 2016; 12(36): 164.
[10] Bello AK, et al. Socioeconomic Status and CKD at Presentation to a Renal Service in the UK. Clin J Am Soc Nephrol. 2008; 3(5): 1316–23.
[11] Bruce MA, et al. Association of Socioeconomic Status and CKD Among African Americans: The Jackson Heart Study. J Am Soc Nephrol. 2010; 55(6): 1001–1008.
[12] Loos-Ayav C, et al. Incidence of CRF in the general population, EPIRAN study. Néphrologie & Thérapeutique. 2009; 5: S250–5.
[13] Xu K, Evans DB, Kawabata K, Zeramdini R, Klavus J, Murray CJL. Household catastrophic health expenditure: a multicountry analysis. Lancet. 2003; 362(9378): 111–117.
[14] Mbaye A, et al. Prevalence of cardiovascular risk factors in a semi-rural setting in Senegal. Ann Cardiol Angéiol. 2018; 67(4): 264–9.
[15] Sumaili EK, et al. High prevalence of undiagnosed CKD among at-risk population in Kinshasa, DRC. BMC Nephrology. 2009; 10(1): 18.
[16] Farouki ME, et al. Profile of diabetic CRF patients at the initiation of hemodialysis in Rabat. Pan Afr Med J. 2013; 15(124): 1–6.
[17] Seck SM, et al. Epidemiology of CKD in northern Senegal: a community-based study in 2012. Pan Afr Med J. 2014; 18(1): 307–315.
[18] Burkhalter F, et al. Prevalence and risk factors for CKD in rural Haiti. Swiss Med Weekly. 2014; 144(5152).
[19] Gummidi B, et al. Catastrophic Health Expenditure among Patients with Nondialysis CKD in Uddanam, India. Kidney Int Rep. 2022; 7(2): 319–321.
[20] Valsa Jose V, et al. Out-of-pocket expenditures and quality of life among hemodialysis patients in Kerala, India. Hemodialysis Int. 2022; 26(4): 569–574.
[21] Baye TA, et al. Economic burden of hemodialysis in Addis Ababa, Ethiopia. Cost Eff Resour Alloc. 2024; 22: 25.
[22] Elshahat S, et al. Impact of CKD on developed countries: a systematic scoping review. PLoS One. 2020; 15(3): e0230512.
[23] Ahoui S, et al. Psychosocial consequences of CKD among hemodialysis patients at CNHU-HKM in Cotonou. Rev Sociol Anthropol Psychol. 2017; 16(10/8): 280–294.
[24] Rattanasompattikul M, et al. Association between catastrophic health expenditures and health-related quality of life in CKD patients in Thailand. Qual Life Res. 2020; 29(11): 2965–2976.
Cite This Article
  • APA Style

    Diop, M., Dioum, M. M., Aguiar, M. F. B., Leye, M. M. M. (2026). Socioprofessional Impact on Patients with Chronic Kidney Disease at Aristide Le Dantec Hospital in Dakar: Out-of-Pocket Expenditures Burden and Catastrophic Household Finances. World Journal of Public Health, 11(3), 264-270. https://doi.org/10.11648/j.wjph.20261103.14

    Copy | Download

    ACS Style

    Diop, M.; Dioum, M. M.; Aguiar, M. F. B.; Leye, M. M. M. Socioprofessional Impact on Patients with Chronic Kidney Disease at Aristide Le Dantec Hospital in Dakar: Out-of-Pocket Expenditures Burden and Catastrophic Household Finances. World J. Public Health 2026, 11(3), 264-270. doi: 10.11648/j.wjph.20261103.14

    Copy | Download

    AMA Style

    Diop M, Dioum MM, Aguiar MFB, Leye MMM. Socioprofessional Impact on Patients with Chronic Kidney Disease at Aristide Le Dantec Hospital in Dakar: Out-of-Pocket Expenditures Burden and Catastrophic Household Finances. World J Public Health. 2026;11(3):264-270. doi: 10.11648/j.wjph.20261103.14

    Copy | Download

  • @article{10.11648/j.wjph.20261103.14,
      author = {Mbathio Diop and Mareme Maty Dioum and Morel Fabrice Bignon Aguiar and Mamadou Makhtar Mbacke Leye},
      title = {Socioprofessional Impact on Patients with Chronic Kidney Disease at Aristide Le Dantec Hospital in Dakar: 
    Out-of-Pocket Expenditures Burden and Catastrophic Household Finances},
      journal = {World Journal of Public Health},
      volume = {11},
      number = {3},
      pages = {264-270},
      doi = {10.11648/j.wjph.20261103.14},
      url = {https://doi.org/10.11648/j.wjph.20261103.14},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.wjph.20261103.14},
      abstract = {Background: Chronic kidney disease (CKD) represents a major public health burden in sub-Saharan Africa, predominantly affecting young working-age adults. Despite free dialysis policies implemented in Senegal since 2012, the broader socioeconomic consequences of end-stage kidney disease (ESKD) on patients and their families remained poorly documented. Aim: This study aimed to estimate the socioprofessional and economic impact of dialysis on ESKD patients and their families in 2019. Setting: The nephrology and dialysis department of Aristide Le Dantec Hospital, a national level III referral center in Dakar, Senegal. Methods: An analytical cross-sectional study was conducted from January to December 2019. Data were collected through medical record reviews and face-to-face interviews. Direct and indirect costs were calculated, and catastrophic health expenditure was assessed using a 20% annual household income threshold. Results: A total of 89 patients were enrolled. The mean age was 47.83 years and 87.36% had no health insurance. Weekly working hours declined from 38.32 before diagnosis to 4.93 hours after. Job loss affected 59.09% of patients. Nearly all patients (89.53%) reported social repercussions, primarily activity limitations. Additionally, 43.68% sold personal assets to cover treatment costs, and 18.39% contracted loans. Catastrophic health expenditure affected 95.98% of patients, with out-of-pocket costs representing 52.86% of total management expenditures. Conclusion: Despite state subsidies, ESKD imposed a devastating socioeconomic burden on patients and families. Strengthening health insurance coverage and expanding social protection for CKD patients is strongly recommended. Contribution: This study provides critical evidence on the socioprofessional consequences of ESKD in West Africa, informing equitable health policy and resource allocation for kidney disease management in low- and middle-income countries.},
     year = {2026}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Socioprofessional Impact on Patients with Chronic Kidney Disease at Aristide Le Dantec Hospital in Dakar: 
    Out-of-Pocket Expenditures Burden and Catastrophic Household Finances
    AU  - Mbathio Diop
    AU  - Mareme Maty Dioum
    AU  - Morel Fabrice Bignon Aguiar
    AU  - Mamadou Makhtar Mbacke Leye
    Y1  - 2026/07/24
    PY  - 2026
    N1  - https://doi.org/10.11648/j.wjph.20261103.14
    DO  - 10.11648/j.wjph.20261103.14
    T2  - World Journal of Public Health
    JF  - World Journal of Public Health
    JO  - World Journal of Public Health
    SP  - 264
    EP  - 270
    PB  - Science Publishing Group
    SN  - 2637-6059
    UR  - https://doi.org/10.11648/j.wjph.20261103.14
    AB  - Background: Chronic kidney disease (CKD) represents a major public health burden in sub-Saharan Africa, predominantly affecting young working-age adults. Despite free dialysis policies implemented in Senegal since 2012, the broader socioeconomic consequences of end-stage kidney disease (ESKD) on patients and their families remained poorly documented. Aim: This study aimed to estimate the socioprofessional and economic impact of dialysis on ESKD patients and their families in 2019. Setting: The nephrology and dialysis department of Aristide Le Dantec Hospital, a national level III referral center in Dakar, Senegal. Methods: An analytical cross-sectional study was conducted from January to December 2019. Data were collected through medical record reviews and face-to-face interviews. Direct and indirect costs were calculated, and catastrophic health expenditure was assessed using a 20% annual household income threshold. Results: A total of 89 patients were enrolled. The mean age was 47.83 years and 87.36% had no health insurance. Weekly working hours declined from 38.32 before diagnosis to 4.93 hours after. Job loss affected 59.09% of patients. Nearly all patients (89.53%) reported social repercussions, primarily activity limitations. Additionally, 43.68% sold personal assets to cover treatment costs, and 18.39% contracted loans. Catastrophic health expenditure affected 95.98% of patients, with out-of-pocket costs representing 52.86% of total management expenditures. Conclusion: Despite state subsidies, ESKD imposed a devastating socioeconomic burden on patients and families. Strengthening health insurance coverage and expanding social protection for CKD patients is strongly recommended. Contribution: This study provides critical evidence on the socioprofessional consequences of ESKD in West Africa, informing equitable health policy and resource allocation for kidney disease management in low- and middle-income countries.
    VL  - 11
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Abstract
  • Keywords
  • Document Sections

    1. 1. Introduction
    2. 2. Materials and Methods
    3. 3. Results
    4. 4. Discussion
    5. 5. Conclusions
    Show Full Outline
  • Abbreviations
  • Author Contributions
  • Data Availability Statement
  • Conflicts of Interest
  • References
  • Cite This Article
  • Author Information